[Is sentinel node biopsy in skin melanoma patients safe?].
Identifieur interne : 003724 ( PubMed/Checkpoint ); précédent : 003723; suivant : 003725[Is sentinel node biopsy in skin melanoma patients safe?].
Auteurs : Dariusz Nejc ; Janusz Piekarski ; Arkadiusz JeziorskiSource :
- Wiadomosci lekarskie (Warsaw, Poland : 1960) [ 0043-5147 ] ; 2005.
Descripteurs français
- KwdFr :
- MESH :
- anatomopathologie : Mélanome, Tumeurs cutanées.
- effets indésirables : Biopsie de noeud lymphatique sentinelle.
- Adulte, Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Incidence, Mâle, Mélanome, Pologne, Sujet âgé, Sujet âgé de 80 ans ou plus, Tumeurs cutanées.
- Wicri :
- geographic : Pologne.
English descriptors
- KwdEn :
- MESH :
- geographic : Poland.
- adverse effects : Sentinel Lymph Node Biopsy.
- pathology : Melanoma, Skin Neoplasms.
- surgery : Melanoma, Skin Neoplasms.
- Adult, Aged, Aged, 80 and over, Female, Humans, Incidence, Male, Middle Aged, Risk Factors.
Abstract
Sentinel node biopsy allow for detection metastases to regional lymph nodes in subclinical phase. The method is currently implemented into clinical practice in Poland.
PubMed: 16119161
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:16119161Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Is sentinel node biopsy in skin melanoma patients safe?].</title><author><name sortKey="Nejc, Dariusz" sort="Nejc, Dariusz" uniqKey="Nejc D" first="Dariusz" last="Nejc">Dariusz Nejc</name><affiliation><nlm:affiliation>Z Kliniki Chirurgii Onkologicznej, Katedry Onkologii, Uniwersytetu Medycznego w Lodzi.</nlm:affiliation><wicri:noCountry code="subField">Uniwersytetu Medycznego w Lodzi</wicri:noCountry></affiliation></author><author><name sortKey="Piekarski, Janusz" sort="Piekarski, Janusz" uniqKey="Piekarski J" first="Janusz" last="Piekarski">Janusz Piekarski</name></author><author><name sortKey="Jeziorski, Arkadiusz" sort="Jeziorski, Arkadiusz" uniqKey="Jeziorski A" first="Arkadiusz" last="Jeziorski">Arkadiusz Jeziorski</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:16119161</idno><idno type="pmid">16119161</idno><idno type="wicri:Area/PubMed/Corpus">003C19</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003C19</idno><idno type="wicri:Area/PubMed/Curation">003C19</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003C19</idno><idno type="wicri:Area/PubMed/Checkpoint">003C19</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003C19</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Is sentinel node biopsy in skin melanoma patients safe?].</title><author><name sortKey="Nejc, Dariusz" sort="Nejc, Dariusz" uniqKey="Nejc D" first="Dariusz" last="Nejc">Dariusz Nejc</name><affiliation><nlm:affiliation>Z Kliniki Chirurgii Onkologicznej, Katedry Onkologii, Uniwersytetu Medycznego w Lodzi.</nlm:affiliation><wicri:noCountry code="subField">Uniwersytetu Medycznego w Lodzi</wicri:noCountry></affiliation></author><author><name sortKey="Piekarski, Janusz" sort="Piekarski, Janusz" uniqKey="Piekarski J" first="Janusz" last="Piekarski">Janusz Piekarski</name></author><author><name sortKey="Jeziorski, Arkadiusz" sort="Jeziorski, Arkadiusz" uniqKey="Jeziorski A" first="Arkadiusz" last="Jeziorski">Arkadiusz Jeziorski</name></author></analytic><series><title level="j">Wiadomosci lekarskie (Warsaw, Poland : 1960)</title><idno type="ISSN">0043-5147</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Melanoma (pathology)</term><term>Melanoma (surgery)</term><term>Middle Aged</term><term>Poland</term><term>Risk Factors</term><term>Sentinel Lymph Node Biopsy (adverse effects)</term><term>Skin Neoplasms (pathology)</term><term>Skin Neoplasms (surgery)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Biopsie de noeud lymphatique sentinelle (effets indésirables)</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Mâle</term><term>Mélanome ()</term><term>Mélanome (anatomopathologie)</term><term>Pologne</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tumeurs cutanées ()</term><term>Tumeurs cutanées (anatomopathologie)</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Poland</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Mélanome</term><term>Tumeurs cutanées</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Biopsie de noeud lymphatique sentinelle</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Melanoma</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Melanoma</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Mâle</term><term>Mélanome</term><term>Pologne</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tumeurs cutanées</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Pologne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Sentinel node biopsy allow for detection metastases to regional lymph nodes in subclinical phase. The method is currently implemented into clinical practice in Poland.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16119161</PMID><DateCreated><Year>2005</Year><Month>08</Month><Day>25</Day></DateCreated><DateCompleted><Year>2005</Year><Month>10</Month><Day>06</Day></DateCompleted><DateRevised><Year>2013</Year><Month>05</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0043-5147</ISSN><JournalIssue CitedMedium="Print"><Volume>58</Volume><Issue>3-4</Issue><PubDate><Year>2005</Year></PubDate></JournalIssue><Title>Wiadomosci lekarskie (Warsaw, Poland : 1960)</Title><ISOAbbreviation>Wiad. Lek.</ISOAbbreviation></Journal><ArticleTitle>[Is sentinel node biopsy in skin melanoma patients safe?].</ArticleTitle><Pagination><MedlinePgn>180-3</MedlinePgn></Pagination><Abstract><AbstractText Label="UNLABELLED">Sentinel node biopsy allow for detection metastases to regional lymph nodes in subclinical phase. The method is currently implemented into clinical practice in Poland.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Type and incidence of complications of sentinel node biopsy in skin melanoma patients. From 01.12.1999 to 01.08.2001 in 80 skin melanoma patients sentinel node biopsy were performed. Patients with excised primary focus and without symptoms of regional and distant metastases were enrolled. There were 42 women (52.5%) and 38 men (47.5%) in studied group (age range: 25-87 years, mean 57, median 58.5). Tumor thickness ranged from 0.5 to 20 mm (mean 3.6, median 2.25). In all patients preoperative lymphoscintigraphy, intraoperative dying and intraoperative detection of gamma radiation were used. Identified sentinel nodes were removed for pathologic examination. Type and incidence of complications were noted. No complications of lymphoscintigraphy and intraoperative dying were observed. In 3 patients (3.7%) intraoperative hemorrhage occurred. No complications were observed in remaining 77 patients. Early postoperative complications were: hematoma (1 patient--1.25%), transient lymphocele (9 patients--11.25%), lymphoedema of extremity (7 patients--8.75%). In 66 of 80 patients in whom selective lymphadenectomy were not performed, late postoperative complications were: persistent lymphoedema of extremity (2 patients of 66--3.0%) and persistent tatoo after dye injection (2 patients of 66--3.0%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Sentinel node biopsy is a safe procedure. Incidence and severity of complications are low.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nejc</LastName><ForeName>Dariusz</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Z Kliniki Chirurgii Onkologicznej, Katedry Onkologii, Uniwersytetu Medycznego w Lodzi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piekarski</LastName><ForeName>Janusz</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Jeziorski</LastName><ForeName>Arkadiusz</ForeName><Initials>A</Initials></Author></AuthorList><Language>pol</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D023362">Evaluation Studies</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><VernacularTitle>Czy biopsja wiezła wartowniczego u chorych na czerniaka skóry jest zabiegiem bezpiecznym?</VernacularTitle></Article><MedlineJournalInfo><Country>Poland</Country><MedlineTA>Wiad Lek</MedlineTA><NlmUniqueID>9705467</NlmUniqueID><ISSNLinking>0043-5147</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008545" MajorTopicYN="N">Melanoma</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011044" MajorTopicYN="N" Type="Geographic">Poland</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021701" MajorTopicYN="N">Sentinel Lymph Node Biopsy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>10</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16119161</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Jeziorski, Arkadiusz" sort="Jeziorski, Arkadiusz" uniqKey="Jeziorski A" first="Arkadiusz" last="Jeziorski">Arkadiusz Jeziorski</name><name sortKey="Nejc, Dariusz" sort="Nejc, Dariusz" uniqKey="Nejc D" first="Dariusz" last="Nejc">Dariusz Nejc</name><name sortKey="Piekarski, Janusz" sort="Piekarski, Janusz" uniqKey="Piekarski J" first="Janusz" last="Piekarski">Janusz Piekarski</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003724 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003724 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:16119161
|texte= [Is sentinel node biopsy in skin melanoma patients safe?].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:16119161" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |